Oligometastatic Prostate Cancer Clinical Trials in Tel Aviv
2 recruitingTel Aviv, Israel
Showing 1–2 of 2 trials
Recruiting
Phase 3
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals450 enrolled142 locationsNCT05939414
Recruiting
Phase 2
Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
Oligometastatic Prostate Cancer
Peter MacCallum Cancer Centre, Australia92 enrolled3 locationsNCT05560659